Pharmacologic management of CD currently consists of 5-aminosalicylic acid, corticosteroids, purine analogs azathioprine, and 6-mercaptopurine, and biologics including anti-tumor necrosis factor (TNF)-α inhibitors. The gene discussed is TNF; the disease is Cowden disease.